| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B |
| EPS (Basic) | $2.27 | $2.08 | $1.95 | $2.02 | $1.34 | $3.33 |
| EPS (Diluted) | $2.26 | $2.07 | $1.95 | $2.02 | $1.34 | $3.33 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Total Assets | $5.0B | $5.1B | $4.3B | $4.3B | $3.7B | $3.2B |
| Current Assets | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.4B | $0.3B | $0.3B |
| Total Liabilities | $4.5B | $4.6B | $3.9B | $3.9B | $3.3B | $2.9B |
| Current Liabilities | — | — | — | — | — | — |
| Stockholders' Equity | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B | $0.3B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.1B |
| Investing Cash Flow | $0.0B | $0.1B | $-0.3B | $-0.3B | $-0.4B | $0.1B |
| Capital Expenditures | — | — | — | — | — | — |
| Financing Cash Flow | $-0.1B | $-0.2B | $-0.0B | $0.4B | $0.4B | $-0.1B |